Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of SKG0201 Injection in Patients With Spinal Muscular Atrophy Type 1 [NA]

View source ↗

Summary

This document reports a clinical study evaluating the safety and efficacy of SKG0201 Injection in patients with spinal muscular atrophy, currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• SKG0201 Injection (SKG0201)

Snippet

Sponsor: Kun Sun | Conditions: Spinal Muscular Atrophy 1 | NA | Status: ACTIVE_NOT_RECRUITING